3-Methoxy-4-methylamphetamine

3-Methoxy-4-methylamphetamine (MMA) is a psychoactive drug and research chemical belonging to the amphetamine class of compounds. It is known for its stimulant, entactogen, and hallucinogenic effects. MMA is structurally related to other amphetamines such as MDMA (ecstasy), Methamphetamine, and 3,4-methylenedioxyamphetamine (MDA), but it possesses distinct pharmacological properties.
Chemistry[edit]
3-Methoxy-4-methylamphetamine (MMA) is a synthetic compound that falls within the broader category of substituted amphetamines. Its chemical structure is characterized by a methoxy group (-OCH₃) attached to the benzene ring at the 3rd position and a methyl group (-CH₃) attached at the 4th position. This molecular configuration is responsible for its unique pharmacological actions.
Pharmacology[edit]
The pharmacological profile of MMA is complex, involving multiple mechanisms of action. It acts primarily as a releasing agent of serotonin, dopamine, and norepinephrine, which are key neurotransmitters in the central nervous system. The increase in these neurotransmitters is responsible for its stimulant and entactogenic effects. Additionally, MMA may interact with various serotonin receptors, which could explain its hallucinogenic properties.
Effects[edit]
The effects of MMA can vary significantly depending on the dose, route of administration, and individual physiology. Commonly reported effects include:
- Euphoria
- Increased energy and alertness
- Enhanced sensory perception
- Emotional openness
- Altered sense of time
However, MMA can also produce adverse effects, such as:
- Anxiety and paranoia
- Nausea and vomiting
- Increased heart rate and blood pressure
- Hyperthermia
- Potential for neurotoxicity and cardiotoxicity
Legal Status[edit]
The legal status of 3-Methoxy-4-methylamphetamine varies by country, but it is often classified as a controlled substance due to its potential for abuse, dependence, and harm. In many jurisdictions, MMA is listed under drug schedules that restrict its manufacture, sale, and possession.
Research and Clinical Use[edit]
As of now, MMA has limited research data available and is not approved for any clinical use. It has been studied in the context of its psychoactive effects and potential neurotoxicity, but further research is needed to fully understand its pharmacology and toxicology.
Safety and Toxicology[edit]
The safety profile of MMA is not well-established, and there is potential for acute and long-term adverse effects. Users may experience immediate side effects like increased heart rate and blood pressure, which can pose risks to individuals with pre-existing cardiovascular conditions. The neurotoxic and cardiotoxic potential of MMA, particularly with chronic use, remains a concern within the scientific community.
This substance-related article is a stub. You can help WikiMD by expanding it.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian